Product Images Diltiazem Hydrochloride

The text seems to be a chemical formula. The formula is not complete, and it is not possible to determine what compound it represents without more information.*

This is a prescription medicine called Diltiazem Hydrochloride, in the form of a 1 mL single-dose container. It should be used intravenously, and any unused portion should be discarded. The container contains 125 mg per 125 mL of Diltiazem Hydrochloride, and the recommended dosage should be followed correctly as per prescription guidelines. It is important to check for leaks before use, and not add supplemental medication or use it in series connections. The container should be stored refrigerated at 2°C to 8°C (36°F to 46°F). The container and port do not contain natural rubberlatex, PVC, or DEHP.*

This is a description of a 125 mL single-dose container of Diltiazem Hydrochloride in 5% Dextrose Injection for intravenous use only. Each mL contains 1 mg of Diltiazem Hydrochloride, USP, and 50 mg of Dextrose Anhydrous, USP, along with other ingredients. It is recommended to check the solution for minute leaks and not to use unless the solution is clear. The solution must not be used in series connections. The container should be stored refrigerated at 2°C to 8°C. This product is Rx only, sterile, unpreserved, and nonpyrogenic. The manufacturer is Exela Pharma Sciences, LLC, and the National Drug Code is 51754-3000-1.*

Diltiazem Hydrochloride in 5% Dextrose Injection is a medication used only for intravenous use. It is provided in a Single-Dose Container with a concentration of > 250 mg per 250 mL, which is equivalent to 1 mg per mL. Each mL of this solution contains several substances, including 1 mg Diltiazem Hydrochloride, USP, 50 mg Dextrose Anhydrous, USP, among others. This medication should be used immediately once it is removed from the overwrap, and the unused portion should be discarded. It is important to check for minute leaks, and the solution should not be used unless it is clear. Supplemental medication should not be added, and it must not be used in series connections. The recommended dosage should be determined by a physician. The bags and ports used do not contain natural rubber latex, PVC, or DEHP. The storage temperature should be 2°C to 8°C (36°F to 46°F). The manufacturer and distributor of this medication are Exela Pharma Sciences LLC, USA, and it is sterile, unpreserved, and nonpyrogenic.*

This is a 250mL single-dose container of Diltiazem Hydrochloride in 5% Dextrose Injection for intravenous use only. Each mL contains Diltiazem Hydrochloride, Dextrose Anhydrous, Citric Acid Monohydrate, Sodium Citrate Dihydrate, Sodium Hydroxide, and/or Hydrochloric Acid, and Water for Injection. It is caution not to use unless the solution clear and there are no minute leaks. This should not be used in series connections and it should be stored refrigerated at 2°C to 8°C. The recommended dosage is mentioned in the prescribing information. The product is manufactured and distributed by Exela Pharma Sciences, LLC. The NDC number is 51754-3500-1. No LOT/ EXP YYYY MM / Serialization information is available.*